GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trellus Health PLC (LSE:TRLS) » Definitions » Notes Receivable

Trellus Health (LSE:TRLS) Notes Receivable : £0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Trellus Health Notes Receivable?

Trellus Health's Notes Receivable for the quarter that ended in Jun. 2024 was £0.00 Mil.


Trellus Health Notes Receivable Historical Data

The historical data trend for Trellus Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trellus Health Notes Receivable Chart

Trellus Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - -

Trellus Health Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Notes Receivable Get a 7-Day Free Trial - - - - -

Trellus Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Trellus Health Notes Receivable Related Terms

Thank you for viewing the detailed overview of Trellus Health's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Trellus Health Business Description

Traded in Other Exchanges
N/A
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.

Trellus Health Headlines

No Headlines